Angiopoietins as Prognostic Markers for Future Kidney Disease and Heart Failure Events after Acute Kidney Injury

Sherry G Mansour1,2, Pavan K Bhatraju3,4, Steven G Coca5

  • 1Clinical Translational Research Accelerator, Department of Medicine, Yale University School of Medicine, New Haven, Connecticut.

Insights

A higher angiopoietin-1 to angiopoietin-2 ratio indicates better vessel stability, significantly reducing risks of chronic kidney disease progression, heart failure, and mortality after acute kidney injury.

Area of Science:

  • Nephrology
  • Cardiology
  • Vascular Biology

Background:

  • Long-term consequences of acute kidney injury (AKI) are not fully understood.
  • Vessel instability, a result of endothelial injury, may be a common factor in chronic kidney disease (CKD) and heart failure development.
  • Angiopoietins are key regulators of vascular homeostasis.

Purpose of the Study:

  • To determine if plasma angiopoietin levels correlate with CKD progression and heart failure admissions post-hospitalization.
  • To investigate the association between the angiopoietin-1 (Angpt-1) to angiopoietin-2 (Angpt-2) ratio and adverse outcomes in patients with and without AKI.
  • To analyze the prognostic value of the Angpt-1:Angpt-2 balance in predicting CKD progression, heart failure, and mortality.

Main Methods:

  • Prospective cohort study of 1503 hospitalized patients.
  • Measurement of plasma angiopoietins (Angpt-1 and Angpt-2) three months post-discharge.
  • Evaluation of associations between the Angpt-1:Angpt-2 ratio and outcomes including CKD progression, heart failure, and all-cause mortality.

Main Results:

  • The highest quartile of the Angpt-1:Angpt-2 ratio was linked to a 72% lower risk of CKD progression and 94% lower risk of heart failure in AKI patients.
  • Among AKI patients, a higher Angpt-1:Angpt-2 ratio was associated with an 82% reduction in mortality.
  • In patients without AKI, the highest Angpt-1:Angpt-2 ratio correlated with significantly lower risks of heart failure and mortality, but not CKD progression.

Conclusions:

  • A higher angiopoietin-1 to angiopoietin-2 ratio is a strong predictor of reduced CKD progression, heart failure, and mortality, particularly in patients with a history of AKI.
  • Vascular homeostasis, as indicated by the Angpt-1:Angpt-2 balance, plays a crucial role in long-term outcomes after AKI.
  • The Angpt-1:Angpt-2 ratio holds potential as a biomarker for assessing cardiovascular and renal risk post-hospitalization.
Abstract

Related Concept Videos

Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
75
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
146
Acute Kidney Injury I: Introduction01:22

Acute Kidney Injury I: Introduction

Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
124
Acute Kidney Injury III: Clinical Manifestations01:29

Acute Kidney Injury III: Clinical Manifestations

Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
147
Acute Kidney Injury V: Interprofessional Care01:20

Acute Kidney Injury V: Interprofessional Care

Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
65
Acute Kidney Injury VI: Nursing Management01:22

Acute Kidney Injury VI: Nursing Management

Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
102